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Obsessive-compulsive disorder (OCD) is a common 
psychiatric disorder that affects approximately 2 % of the global 
population and is characterized by the presence of intrusive and 
distressing thoughts (obsessions) and/or repetitive behaviors 
(compulsions). Over the last few decades, molecular neurobiology has 
uncovered several genes whose deficiency in mice results in behavioral 
traits associated with human OCD. However, the mechanisms that 
underlie OCD remain largely unknown. Here I show the relationship 
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between OCD and Ninjurin 1 (Ninj1), a small cell adhesion molecule 
that is known to play various roles in nerve regeneration and 
inflammation. Ninj1 knockout (KO) mice exhibit compulsive 
grooming-induced hair loss and self-made lesions as well as increased 
anxiety-like behaviors that are responsive to fluoxetine, a first-line 
OCD treatment. Ninj1 is highly expressed in cortico-thalamic circuits, 
which are critical areas that are implicated in OCD. Histological 
analysis reveals that Ninj1 is predominantly expressed in cortico-
thalamic circuits, and neuron-specific Ninj1 conditional KO mice 
manifest aberrant phenotypes similar to the global Ninj1 KO mice. 
Intriguingly, Ninj1 KO brains display reduced numbers of functional 
synapses and impaired neuronal branching, which results in altered 
neurotransmission in thalamic circuits. Moreover, the disruption of 
Ninj1 leads to abnormalities in glutamate signaling, which reflects the 
function of Ninj1 as a regulator of N-methyl-D-aspartate (NMDA)-type 
glutamate receptor stability. Collectively, my results demonstrate that 
Ninj1 deficiency in mice causes OCD-like behaviors and that Ninj1 
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1. Obsessive-compulsive disorder 
Obsessive-compulsive disorder (OCD) is a common psychiatric 
disorder that affects approximately 2 % of the global population and is 
characterized by the presence of intrusive and distressing thoughts 
(obsessions) and/or repetitive behaviors (compulsions) [1,2]. The World 
Health Organization (WHO) has ranked OCD in the top ten nonfatal 
global burdens, in terms of diminished quality of life [3,4]. OCD affects 
men and women in roughly equal numbers and usually starts during 
childhood [4,5]. People with OCD generally repeat thoughts, doubts, or 
images about different things such as fear of germ contamination and 
dirt. They do the same rituals compulsively such as washing hands, 
locking and unlocking doors, or counting of things [4]. Most OCD 
patients are aware of the behaviors they are doing, however, they could 
not control and stop their unwanted thoughts and behaviors [4]. Despite 
decades of research and tremendous efforts by many scientists, the 
prevalence of OCD has not decreased [2]. Our understanding of the 
biological mechanisms that underlie this disease is limited, presumably 
2 
 
owing to etiological complexity and difficulties in examining the living 
human brain. 
Several lines of evidence from human studies indicate that there 
are genetic components to the pathogenesis of obsessive-compulsive 
disorder (OCD) [6,7]. Using genetically engineered mice, several genes 
related to OCD have been revealed. Specifically, the deletion of the 
Hoxb8, Sapap3, or Slitrk5 gene in mice recapitulated several key 
features of OCD, including (i) repetitive behaviors (excessive grooming 
to the point of hair loss and self-made lesions), (ii) increased anxiety-
like behaviors that were ameliorated by treatment with the selective 
serotonin reuptake inhibitor fluoxetine, and (iii) altered glutamate 
signaling in the brain [8-10]. Although many important advances in the 
understanding of the aetiology of OCD have been made, the molecular 
basis of this disorder remains poorly understood. Interestingly, a wide 
variety of cell adhesion molecules have been causally implicated in 
psychiatric disorders, including OCD, autism, and schizophrenia [11-
13]. The cell adhesion molecule Ninj1 has diverse functions in 
peripheral tissues [14-16]; however, its roles in the central nervous 




Nerve injury-induced protein 1 (Ninjurin1 or Ninj1), a 152-
amino-acid cell adhesion molecule, was originally identified based on 
its strong upregulation after axotomy in neurons and in Schwann cells 
surrounding the distal sciatic nerve segments in rats in 1996 [14] 
(Figure 1A). In mammals, Ninj1 belongs to Ninjurin family consisting 
of Ninj1 and Ninj2, which share conserved hydrophobic regions in their 
transmembrane domains [17]. However, Ninj1 and Ninj2 do not contain 
comparable adhesion motifs nor do they have similar expression 
patterns in tissues. In addition, Ninjurins have no considerable 
homology to any other known proteins [14].  
Mouse Ninj1 protein is composed of a N-terminal (amino acid 
(a.a.) 1-71) and a C-terminal (a.a. 140-152) extracellular domains, two 
transmembrane domains (a.a. 72-100 and a.a. 118-139), and a 
cytoplasmic domain (a.a. 101-117, Figure 1B, left) [14]. Human Ninj1 
is a 152-amino acid protein with both its N- and C-terminus exposed 
extracellularly (a.a. 1-80 and a.a. 142-152), a short intracellular 
segment (a.a. 102-119), and two transmembrane domains (a.a. 81-101 
and a.a. 121-141, Figure 1B, right). It has been known that Ninj1 can 
interact with each other in a homophilic binding manner through an N-
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terminal extracellular 12 residue binding motif located from Pro26 to 
Asn37 (PPRWGLRNRPIN) to promote nerve regeneration [18] (Figure 
1A).  
Ninj1 is expressed in many kinds of tissues and cells, 
predominantly in those of epithelial origin such as liver, kidney, thymus 
[18]. In addition to a suggested role in promoting nerve regeneration, 
Ninj1 has been shown to be involved in non-neuronal 
pathophysiological conditions [19]. Ninj1 is temporally increased in 
macrophages and mediates the regression of hyaloid blood vessels, a 
transient existing network of capillaries responsible for the growth and 
maturation of the lens, via a close interaction between macrophages and 
vascular endothelial cells during ocular development [20]. Furthermore, 
Ninj1 is reported to be expressed in myeloid cells and modulated the 
migration of myeloid cells to central nervous system inflammatory 
lesions in an autoimmune disease multiple sclerosis and its animal 
model, experimental autoimmune encephalomyelitis (EAE) [15,16,21]. 
In addition, Ninj1 contributes to intravascular crawling of myelin-
reactive T cells on cerebral blood vessels to mediate neuronal 
inflammation in multiple sclerosis [22]. Recently, Ninj1 is reportedly 
elevated under inflammatory conditions and contributed to 
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inflammation not only by mediating leukocyte migration, but also by 
modulating Toll-like receptor 4 (TLR4) [23]. Taken together, Ninj1 is 
an important factor in pathophysiological inflammation and a novel 
therapeutic target for inflammatory conditions such as multiple 
sclerosis and sepsis. 
 In addition to its roles in inflammation, Ninj1 is implicated in 
the regulation of vascular formation. Yin et al. reported that inhibition 
of Ninj1 restores erectile function through angiogenic effects in the 
diabetic mice [24]. Very recently, Ninj1 has been shown to negatively 
regulates the formation of new blood vessels by reducing the trophic 
effects of capillary pericytes [25]. 
Although the protein Ninj1 plays diverse roles in peripheral 
tissues, its involvement in the central nervous system (CNS) and 









(A) Primary sequence of mouse Ninj1. Ninj1 consists of 152 amino 
acid (a.a.) with N-terminal and C-terminal ectodomains, two 
transmembrane domains (orange), and a short cytoplasmic domain. It 
can mediate the homophilic binding via the 12-residue adhesion 
domain (red) located at a.a. 26-37 on the N-terminal extracellular 
domain. (B) Structure of mouse Ninj1 and human NINJ1. Adhesion 





Figure 1. Sequence and structure of Ninj1. 
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PURPOSE OF THIS STUDY 
 
Obsessive-compulsive disorder (OCD) is a severe anxiety-related 
disorder that affects approximately 2 % of the population worldwide, 
regardless of age, gender, or cultural class. WHO has ranked OCD as 
one of the top ten non-fatal disorders that carry the highest global 
burden in terms of diminished quality of life. However, the mechanisms 
that underlie OCD remain to be elucidated due to the heterogeneity of 
this biological disorder and the involvement of a battery of genes.  
Although the cell adhesion molecule Ninj1 plays diverse roles 
in peripheral tissues, its involvement in the central nervous system 
(CNS) remains uncharacterized. Moreover, Ninj1 knockout (KO) mice 
manifest abnormal behavioral phenotypes, which are likely 
remininescent to neuropsychiatric disorder OCD. Therefore, in this 
study I investigated the relationship between Ninj1 and OCD as well as 
its functions in CNS. I expect that my findings could contribute to 




MATERIALS AND METHODS 
 
1. Animals 
The mice were housed on a 12-hour light-dark cycle, with the dark 
cycle occurring from 19:00 PM to 07:00 AM and had access ad libitum 
to food and water. All animal experiments were approved by the 
Committees on Animal Research at Seoul National University 
(approval number SNU-130617-4-3). 
 
1.1 Ninj1 knockout mice. Ninj1 knockout (KO) mice were generated 
as described previously [16]. Briefly, Ninj1 KO mice were generated  
by  removing  exon 1 of the Ninj1 gene located on the chromosome 
13 by homologous recombination. Ninj1 KO mice were backcrossed 
with the C57BL/6J strain for at least ten generations. The primer 
sequences for genotyping are as follows: wild-type (forward), 5ʹ-GAG 
ATA GAG GGA GCA CGA CG-3ʹ, neo (forward): 5ʹ-ACG CGT CAC 





1.2 “Knockout first”, LacZ-tagged Ninj1 tm1a mutant mice. 
Heterozygous Ninj1 tm1a mutant mice (Ninj1+/tm1a) were generated by 
the Knockout Mouse Project (KOMP; University of California, Davis, 
USA) using the “knockout-first” strategy [26]. In the Ninj1 tm1a allele, 
a “SA-LacZ-pA” trapping cassette was inserted between exons 1 and 2 
of the Ninj1 gene to disrupt the expression of Ninj1 mRNA. 
Genotyping primers used are as follows: for wild-type allele, forward 
(Ninj1-F, 5ʹ-AAC CAG GGG AAT CAA GGA CAG TAG C-3ʹ) and 
reverse (Ninj1-ttR, 5ʹ-CCC ATC TCT CAT TAT CCC ATG CAG C-3ʹ); 
for Ninj1 tm1a allele, forward (lox-F, 5'-GAG ATG GCG CAA CGC 
AAT TAA TG-3ʹ) and reverse (Ninj1-R, 5ʹ-ATC AGC TAT CCA TCC 
ATG CCT ACG G-3ʹ). 
 
1.3 Generation of Ninj1 conditional knockout (Ninj1 c.KO) 
mice. 
Heterozygous Ninj1 tm1a mutant mice (Ninj1+/tm1a) were mated with 
Flpo mice [C57BL/6N-Tg(CAG-Flpo)1Afst/Mmucd; University of 
California, Davis MMRRC Repository, USA] to obtain heterozygous 
Ninj1 tm1c mice (Ninj1+/tm1c or Ninj1+/flox mice), which do not have the 
trapping cassette. In parallel, Ninj1 KO mice that carry one copy of the 
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CreSyn transgene (Ninj1-/-; CreSyn) were produced by crossing Ninj1 KO 
mice with synapsin I-Cre mice [B6.Cg-Tg(Syn1-cre)671Jxm/J; The 
Jackson Laboratory, USA]. Next, the Ninj1+/flox mice were bred with 
Ninj1 KO mice bearing CreSyn (Ninj1-/-; CreSyn), resulting in the 
production of control (Ninj1+/-, Ninj1+/-; Cresyn, Ninj1-/flox) and Ninj1 
c.KO (Ninj1-/flox; Cresyn) mice. Genotyping primers used are as follows: 
for Cresyn transgene, forward (5ʹ-GCG GTC TGG CAG TAA AAA CTA 
TC-3ʹ) and reverse (5ʹ-GTG AAA CAG CAT TGC TGT CAC TT-3ʹ); 
for tm1c allele, forward (Ftm1c, 5ʹ-AAG GCG CAT AAC GAT ACC AC-
3ʹ) and reverse (Rtm1c, 5ʹ-CCG CCT ACT GCG ACT ATA GAG A-3ʹ).  
 
1.4 Genotyping procedure. Genotyping of mice was performed by 
polymerase chain reaction (PCR) analysis of genomic DNA isolated 
from toe tissue using the following procedure. Toe was incubated in 
lysis buffer of 1 % SDS, 0.1 M NaCl, 100 mM EDTA, 50 mM Tris (pH 
8.0), and 1 µg/µL proteinase K at 55 oC overnight. NaCl (5 M) was 
then added to remove cell debris, followed by DNA precipitation with 
cold 2-propanol at –20 oC. DNA pellets were washed with cold 70 % 
ethanol. Five hundred nanograms DNA was used as templates for PCR. 
Products were run on 1.2 % agarose gels, followed by staining with 
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SYBR® green dye (Life technologies, USA) for visualization. 
 
2. Inclusion criteria of hair loss 
A mouse is recorded to have hair loss phenotype if it does not have hair 
in individual or multiple areas on its body or belly. 
 
3. Behavioral tests 
All the analyses presented in this study were performed with adult mice, 
which were littermates from mated heterozygotes or homozygotes, in a 
strict gender- and age-matched manner. The behavioral tests were 
conducted with the mice aged 8–20 weeks old by researchers blinded to 
the genotype of the mice. The examiners of the behavioral analysis 
were not blinded to the experimental groups, unless specified otherwise, 
as Ninj1 KO mice showed hair loss phenotype. However, the 
behavioral analyses were confirmed by at least two independent 
researchers. 
 
3.1 Grooming test. Grooming test was performed from 19:00–21:00 
PM [27]. Mice were individually habituated to novel cages [25 cm 
length (L) x 20 cm width (W) x 20 cm height (H)] for 10 minutes. 
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Immediately thereafter, the mice were recorded by a video camera 
(Samsung HMX-F80; Korea). The total time spent grooming the face, 
head, or body was measured over 1-hour interval and presented as a 
percentage of the observation period. Abbreviations: L, length; W, 
width; H, height. 
 
3.2 Marble-burying test. The marble-burying test was conducted as 
previously described [28]. Mice were individually placed in plastic 
cages (25 cm x 20 cm x 20 cm) that contained 5-cm-deep fresh bedding 
material. Twenty marbles (15 mm in diameter) were pre-arranged in 5 x 
4 evenly spaced rows on top of this material. After 30 minutes, the 
number of buried marbles was counted. A marble was considered to be 
buried if at least two-thirds of its volume was covered by the bedding 
material.  
 
3.3 Nestlet-shredding test. The nestlet-shredding test was performed 
as described previously [28]. Prior to the day of the experiment, the 
materials were dried at 55oC overnight. The tested mouse was given 
one 5 cm x 5 cm shreddable cotton square (Nestlet; Ancare, USA) in a 
plastic cage (25 cm x 20 cm x 20 cm) for 30 minutes. The remaining 
13 
 
materials were collected and dried at 55oC overnight. The weight of the 
nesting material that was shredded was calculated by weighing the 
dried nestlet before and after the test.  
 
3.4 Open-field test. The open-field test was performed as previously 
described [9]. Each mouse was placed in the center of an open-field 
apparatus (40 cm x 40 cm x 40 cm) and then allowed to move freely for 
10 minutes. The behavior of the mice was recorded using the video 
camera. The data were analyzed using EthoVision XT (Noldus, 
Netherlands) in a blind manner.  
 
3.5 Elevated plus maze test. The elevated plus-maze (EPM) test was 
conducted as described previously with slight modification [9]. Plus 
maze apparatus is made of plastic material (closed arms, 25 cm x 5 cm 
x 15 cm; open arms, 25 cm x 5 cm x 0.5 cm). The arms of the maze 
were arranged orthogonally 50 cm above the floor. All of the mice were 
transferred to the behavioral testing room 1 hour before the first trial. 
To begin a trial, each mouse was placed at the center of the apparatus 
facing an open arm; then, it was allowed to move freely in the maze for 
8 minutes. The EPM test was recorded using the video camera. The 
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maze was cleaned with a 70 % ethanol solution and dried after each 
trial to eliminate possible odour cues left by the previous mice. The 
data were collected and analyzed manually in a blind manner.  
 
3.6 Three-chamber test. The test was performed as described 
previously with minor modifications [27]. The three-chamber apparatus 
consists of a transparent glass box with partitions dividing the box into 
three chambers (20 cm x 45 cm x 25 cm for each). There are two small 
entrances (5 cm x 5 cm) between each chamber, which can be opened 
or closed easily with glass doors. The wire cages used to contain the 
stranger mice are steel cylinder (12 cm in height, 9.0 cm in diameter, 
and 1 cm bars spaced). Mice were habituated to the testing room for at 
least 1 hour before starting behavioral tasks. To begin a trial, a tested 
mouse was introduced into the middle chamber and left to habituate for 
5 minutes, while the two entrances to the center chamber were closed; 
then, an unfamiliar mouse (stranger) was placed into a wire cage in one 
of the side chambers. Next, the two entrances were opened to allow the 
tested mouse to freely explore all three chambers for 5 minutes. Time 
spent in each chamber and time spent exploring the targets were 




3.7 Gait analysis. The apparatus has walls made of plastic and is 20 
cm in height to prevent mice from escaping and 50 cm in length, with 
white papers placed along the floor of the entire apparatus. Mouse paws 
were dipped in red ink (forepaws) and blue ink (hindpaws). Mice were 
then introduced at the end of the apparatus and allowed to move freely 
along the corridor of the apparatus. The stride length for a trial was 
calculated as the longest stride for that trial.  
 
3.8 Morris water maze test. The test was conducted similar to the 
method described previously [29]. The Morris water maze apparatus is 
a circular plastic pool (120 cm in diameter) that was filled with water 
(~23 oC) containing white and non-toxic tempera paint to make it 
opaque. A circular steel platform (12 cm in diameter) was submerged 1 
cm beneath the surface of the water. For visible platform task, mice 
were tested for their ability to locate the submerged platform that was 
marked with a flag. For hidden platform test, mice were trained three 
trials per day with an inter-trial interval of 1 hour to find the hidden 
platform in the tank for five consecutive days. At day 6, the probe trial 
was given for 60 seconds with the platform removed from the pool. 
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Distance moved, numbers of crossing over the platform area, and 
percentage of time spent in four quadrants of the pool were analyzed 
using the EthoVision XT.  
 
3.9 Hot plate test. Mice were placed on a hot plate apparatus (Socrel, 
DS-37; Italy) at 55 oC. The escape latency was measured as the time for 
the mouse to flick/lick its paws. A maximum cutoff time of 60 seconds 
was used to prevent thermal injury occurring to mice. 
 
4. Plasmids. Ninj1 expression vectors were constructed as previously 
described [20,30]. Briefly, full-length mouse Ninj1 (a.a. 1-152, 
NM_013610) cDNA was produced by reverse transcription (RT)-PCR 
from NIH-3T3 mouse fibroblasts and inserted into pCS2(+) (Myc 
tagged) plasmid. Ninj1 was subsequently subcloned into pCS2(+)-GFP 
vector (GFP-Ninj1) or pTag2B-Flag (Flag-Ninj1). Plasmid of EGFP-N1 
was obtained from Clontech (USA). For neuroligin 1 expression vector, 
plasmid of HA-tagged Neuroligin 1 (pCAG-HA-NL1) was purchased 
from Addgene (plasmid #15260, generated by Dr. Peter Scheiffele’s 
lab). Plasmid of SEP-tagged NR2A (pCI-SEP-NR2A) was from 




5. RNA interference. For Ninj1 knockdown by small interfering 
RNA (siRNA), siNinj1 against mouse Ninj1 (NM_013610) was 
synthesized and characterized as previously described [31]. Negative 
control  siRNAs (siCtrl) was from Bioneer Inc. (Daejeon, Korea). 
Sequences of the siRNAs are as follows: siCtrl: 5’-CCT ACG CCA 
CCA AUU UCG UdTdT-3’, siNinj1: 5’-ACC GGC CCA UCA AUG 
UAA ACC AUU A-3’. The cells were transfected for 72 hours with 50 
pmol for 60 mm dish or 10 pmol for each well of 24-well plate of the 
siRNAs using Lipofectamine 2000 (ThermoFisher Scientific, USA) 
following the manufacturer's instructions. 
 
6. Primary culture of cortical neurons and neuronal 
tranfection. 
Mouse embryos at embryonic days 16.5–18.5 were isolated and 
incubated with trypsin-EDTA and DNAse for 20 minutes. After 
neutralization with fetal bovine serum (FBS), cortices were dissociated 
slowly with pipette 10 ml (15 times) and further with pipette 5 ml (10 
times). Dissociated cells were filtered through cell strainer (70 µm; BD 
Bioscience, USA). After centrifuged and counted, cells were 
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resuspended in Neurobasal media supplemented with B27, glutamine, 
100 units/mL penicillin, and 100 µg/mL streptomycin (all were from 
Gibco, Invitrogen, USA) and seeded onto 60 mm dishes or 24-well 
plates coated with 0.05 mg/mL poly-D-lysine (P6407; Sigma, USA). 
Neurons were maintained in an incubator with a humidified atmosphere 
of 95 % O2 and 5 % CO2 at 37 
oC. Half of media were changed after 3 
days in vitro (DIV 3) with fresh media supplemented with 
arabinofuranosyl cytidine (Ara-C; Sigma, USA) at final concentration 
of 1 µg/mL. From DIV 4, half of media were changed with fresh media 
every 3 days. For neuronal transfection, cortical neurons were 
transfected with indicated vectors on DIV 4 or DIV 7 using 
Lipofectamine 2000 reagent according to the manufacturer’s protocols. 
 
7. Preparation of synaptosomes and synaptosomal 
fractions.  
The brains of 8-week-old mice were isolated, cut into small pieces with 
scissors, and homogenized in ice-cold HEPES-sucrose buffer (320 mM 
sucrose and 4 mM HEPES; pH 7.4) that was supplemented with a 
protease inhibitor cocktail (Calbiochem, USA). Homogenates (Hom.) 
were centrifuged at low-speed (1000×g for 5 minutes) to obtain the P1 
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pellet (nuclear pellet and debris). The supernatant (S1, synaptosome 
suspension) was subsequently centrifuged at high speed (10,000×g for 
15 minutes) to get pellet P2 (crude synaptosomal fraction) and 
supernatant (S2, light membrane and cytosolic fraction). Next, the P2 
pelleted fraction was resuspended in the ice-cold HEPES-sucrose buffer 
and re-centrifuged at 10,000×g for 15 minutes to obtain pellet P2’ 
(washed synaptosomal fraction). The P2’ pelleted fraction was further 
lysed by hypo-osmotic shock in nine volumes of ice-cold distilled water 
that contained the protease inhibitor cocktail, pipetted 3 times and 
rapidly supplemented with ice-cold 1 M HEPES stock solution, which 
was adjusted to a final concentration of 4 mM HEPES, to obtain S3 
(lysed synaptosomal fraction). S3 was then centrifuged at 21,000×g for 
20 minutes to yield pellet LP1 (synaptosomal membrane fraction) and 
supernatant S3’ (crude synaptic vesicle fraction). Then, 10 µg of total 
protein from each fraction was subjected to Western blot analysis.  
 
8. Cell culture, transfection, and inhibitor treatment. 
Human Embryonic Kidney 293T (HEK293T) cells were cultured in 
Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 
10 % (ν/ν) FBS, 100 units/mL penicillin, and 100 µg/mL streptomycin 
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at 37 oC in an incubator with a humidified atmosphere of 5 % CO2 and 
95 % O2. Cells were transfected with indicated plasmids using 
polyethylenimine reagent (PEI; Sigma, USA). Cells were incubated for 
8 hours with cycloheximide (CHX, 500 μM; Sigma, USA), in the 
presence or absence of lysosomal inhibitors (50 mM NH4Cl and 100 
μM chloroquine; Sigma, USA) or a proteasome inhibitor (10 μM 
MG132; Calbiochem, USA). After treatment, cells were lysed and 
subjected to Western blot analysis. 
 
9. Antibodies.  The anti-Ninj1 rabbit polyclonal antibody was 
generated and characterized as previously described [30]. Antibodies 
used for the Western blots and/or immunostainings are β-actin (Sigma; 
A2066, 1:5000), α-tubulin (Biogenex; MU-121UC, 1:5000), GAPDH 
(Santa Cruz; SC-365062, 1:1000), NMDAR 1 (Cell Signaling 
Technology; 5704S, 1:2000), NMDAR 2A (Millipore; 05-901R, 
1:2000), NMDAR 2B (ThermoFisher Scientific; MA1-2014, 1:2000), 
GluR1 (Abcam; ab31232, 1:2000), GluR2 (Millipore; MAB397, 
1:2000), NeuN (Millipore;  MAB377, 1:500), PSD95 (Neuromab; 73-
028, 1:2000), synaptophysin (Millipore; MAB5258-20UG, 1:2000), 
synapsin (BD Biosciences; 611392, 1:2000), FosB (Santa Cruz; SC-48, 
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1:200), c-Fos (Santa Cruz; SC-52, 1:1000), GFP (Abcam; Ab6556, 
1:200), Flag (Sigma; F1804, 1:500), and β-galactosidase (Millipore; 
AB1211-5MG, 1:200). 
 
10. Western blot analysis. Specimens were homogenized in a lysis 
buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM 
Na2EDTA, 1 mM EGTA, 1 % Triton, 2.5 mM sodium pyrophosphate, 1 
mM beta-glycerophosphate, 1 mM Na3VO4, and 1 µg/mL leupeptin 
plus the protease inhibitor cocktail. Protein concentrations were 
measured by the BCA protein assay kit (Pierce, USA). Total proteins 
were separated by SDS-PAGE. Proteins with low molecular weight 
such as Ninj1 were separated on 12.5 % tricine gels.  
 
11. Histochemical analysis of reporter gene expression. 
Cryosections (16 µm) were equilibrated in 0.1 M phosphate-buffered 
saline (PBS) at pH 7.4 for 15 minutes at room temperature. Samples 
were incubated with X-gal solution containing 2 mg/mL 5-bromo-4-
chloro-3-indolyl-β-D-galactopyranoside (ThermoFisher Scientific, 
USA), 0.5 % Nonidet P-40 (NP-40), 5 mM potassium ferrocyanide, and 
5 mM potassium ferricyanide in PBS at 37 oC overnight. Reaction was 
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stopped by rinsing three times (5 minutes each) with PBS. Samples 
were counterstained with nucleus fast red (NFR) solution (Sigma, 
USA), dehydrated in a series of graded ethanol, cleared in xylene, and 
mounted with Crystal Mount (Biomeda, USA). Samples were examined 
under a microscope (Leica DM5000B; Leica Microsystems, Inc., 
Germany). Multiple images covering whole-brain sections were merged 
by photoshop to obtain panoramic images of brain stained with X-gal. 
 
12. Immunohistochemical analysis. Mice were perfused with 
PBS (pH 7.4) and 4 % paraformaldehyde (PFA) in PBS. Brains were 
isolated, fixed in 4 % PFA/PBS overnight, dehydrated in series of 
gradient sucrose (10, 20, and 30 %) in PBS. After embedded in optimal 
cutting temperature (OCT) embedding compound (Tissue-Tek, Japan), 
brains were coronally sectioned into 16 µm slices by free-floating 
method using a microtome (HM525; Thermo Scientific, USA). Brain 
slices were washed three times (5 minutes each) with PBS (pH 7.4), 
blocked with blocking buffer containing 0.3 % Triton X-100 and 5 % 
(ν/ν) donkey serum (Sigma, USA). Primary antibodies were diluted in 
blocking buffer and incubated at 4 oC overnight. On the following day, 
samples were washed three times (10 minutes each) with PBS (pH 7.4), 
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and treated with Alexa 488- or 546-conjugated donkey secondary 
antibodies (Molecular Probe, Invitrogen, USA) for 1 hour at room 
temperature. Samples were counterstained with Hoechst 33442 
(Molecular Probe, Invitrogen, USA) and mounted on silane-coated 
glass slides (Muto-Glass, Tokyo, Japan) with Gel Mount (Biomeda, 
USA). Samples were visualized under a confocal microscope (LSM 
700; Carl Zeiss, Germany).  
 
13. Immunocytochemical analysis. Samples were fixed in 4 % 
PFA/PBS or cold methanol for 10 minutes. After permeabilization with 
0.2 % Triton X-100/PBS (pH 7.4) for 10 minutes on ice, non-specific 
proteins were blocked with the blocking buffer. Primary antibodies and 
fluorochrome-conjugated secondary antibodies were treated following 
the above procedure for immunohistochemical analysis. 
 
14. Golgi staining. Golgi staining was performed by using standard 
Golgi-Cox impregnation technique with the FD Rapid GolgiStain Kit 
(Neurodigitech, USA). Brains of 8-week-old WT and Ninj1 KO mice 
were transcardially perfused with heparinized PBS (pH 7.4) and post-
fixed with 4 % PFA. Brains were impregnated in Golgi-Cox solution of 
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the kit for 18 days at room temperature (~25 oC) in the dark. Serial 
coronal sections at 150 μm thickness of mouse brains were obtained by 
using the microtome (HM525) and stained with the kit following 
strictly the manufacturer’s protocol. Neurons were visualized under a 
microscopy (Leica DM5000B) at ×10- and ×40-magnifications. 
 
15. Transmission electron microscopy. Eight-week-old WT and 
Ninj1 KO mice were deeply anesthetized, intracardially perfused with 
heparinized PBS (pH 7.4), and fixed with a freshly prepared fixative 
solution containing 2.5 % glutaraldehyde and 2 % PFA in PBS (pH 7.4). 
Brains were isolated, gradually frozen in dry ice-cold isopentane 
(Junsei, Korea), and sectioned with the microtome at 100-μm thickness. 
The sections of brain were post-fixed in the modified Karnovsky’s 
fixative solution of 2.5 % glutaraldehyde and 2 % PFA in 0.05 M 
sodium cacodylate buffer (pH 7.2) for 2 hours at 4 oC, osmicated with 
1 % osmium tetroxide in 0.05 M sodium cacodylate buffer (pH 7.2) for 
2 hours at 4 oC, dehydrated in graded ethanol series (30, 50, 70, 80, 90, 
and three times 100 %; for 10 minutes each) at room temperature, 
embedded in a mixture of propylene oxide and Spurr’s resin for 2 hours, 
and polymerized for 24 hours at 70 oC. Ultrathin sections containing 
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striatum (70 nm) were cut with RMC ultramicrotome (MT-X; Tucson, 
Arizona, USA), mounted on formvar-coated nickel grids, stained with 
2 % uranyl acetate and Reynold’s lead citrate, and examined under an 
electron microscope (JEOL JEM-1010; Tokyo, Japan) equipped with a 
GaJ05 CCD camera (Gatan Inc., USA) at an electron beam of 80 kV. 
Samples were randomly photomicrographed at a ×60,000 magnification 
and used for quantification. 
 
16. Neurochemical analysis. Samples were collected from the 
cerebrums of WT and Ninj1 KO mice. All specimens were 
homogenized in 0.1 M perchloric acid in glacial acid (Sigma, USA) 
containing 100 ng/mL 3,4-dihydroxybenzylamine (DHBA; Sigma, 
USA) as an internal standard. Homogenates were centrifuged for 10 
minutes at 10,000g. After microfiltration, supernatants were analyzed 
for levels of glutamate, norepinephrine, dopamine, serotonin, and 5-
hydroxyindoleacetic acid (5-HIAA, the main metabolite of serotonin) 
with corresponding standards purchased from Sigma(USA), using high-
performance liquid chromatography-electrochemical detection (HPLC-




17. Cell surface biotinylation assay. Biotinylation was carried 
out following the previously described protocol [32]. Briefly, cells were 
washed twice with ice-cold PBS, incubated at 4 oC with 0.5 mg/mL 
Sulfo-NHS-LC-biotin (Pierce, USA) for 45 minutes, washed twice with 
PBS, and neutralized with 1X tris-buffered saline (pH 7.6). Cell lysates 
were prepared in a cell lysis buffer containing NP-40. After precipitated 
with streptavidin-conjugated beads (GE Healthcare, USA), biotinylated 
proteins were eluted by boiling with loading sample buffer and 
subjected to Western blot analysis. 
 
18. Whole-cell patch-clamp recordings for brain slices. 
Nine-to 11-week-old male WT and Ninj1 KO littermates were 
anesthetized by intraperitonial injection of avertin (2, 2, 2-
tribromoethanol) and sacrificed. The isolated brains were immersed in 
ice-cold artificial cerebrospinal fluid (ACSF; in mM: 125 NaCl, 2.5 
KCl, 1.25 NaH2PO4, 25 NaHCO3, 25 dextrose, 2 CaCl2, 2 MgCl2, 3 Na-
pyruvate, and 1 ascorbic acid; maintained at pH 7.4 by gassing with 
95 % O2 and 5 % CO2) and sliced into 250µm-thick coronal sections 
using a Vibratome (VT-1200S; Leica, Germany). The slices were 
transferred to an incubation chamber filled with NMDG recovery 
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solution (in mM: 92 N-methyl-D-glucamine (NMDG), 92 HCl, 30 
NaHCO3, 2.5 KCl, 0.5 CaCl2, 10 MgSO4, 1.2 NaH2PO4, 20 HEPES, 5 
Na-ascorbate, 3 Na-pyruvate, 2 thiourea, and 25 dextrose, maintained at 
pH 7.4 by gassing with 95 % O2 and 5 % CO2) for 15 minutes at 36 
oC. 
The slices were then maintained in oxygenated ACSF at room 
temperature for at least 1 hour prior to use. Ventral lateral (VL) 
thalamic neurons were recorded in oxygenated ACSF at 28–30 oC and 
visualized under an upright microscope (BX-51WI; Olympus, Japan). 
Whole-cell patch clamp recordings were performed using glass pipettes 
(3–4 MΩ) filled with an internal solution (in mM: 130 K-gluconate, 2 
NaCl, 4 MgCl2, 20 HEPES, 4 Na2ATP, 0.4 Na3GTP, and 0.5 EGTA, pH 
7.25, 290–295 mOsm). VL thalamic neurons were ruptured at –67mV 
holding, and all recording processes were performed at that voltage to 
negate inhibitory post-synaptic current (IPSC) influence. Miniature 
excitatory post-synaptic current (mEPSC) was recorded for at least 2 
minutes at voltage clamp gap-free mode. The cells were treated with 1 
μM tetrodotoxin (TTX) and 10 μM bicuculine by bath application 
during whole-cell recordings. Access resistance was routinely 
monitored throughout the recordings, and data were excluded if the 
access resistance varied by more than 25 % of the initial state or the 
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holding current was not stable. All data were acquired with a patch 
clamp amplifier (Multiclamp 700B; Molecular Devices, USA), 
digitized at 1kHz with an A-D converter (Digidata 1550; Molecular 
Devices, USA), and 2 minutes of each recording was analyzed using 
Clampfit (Molecular Devices, USA). 
 
19. Drug treatment. Mice were given fluoxetine with a dose of 18 
mg/kg (LKT Laboratories, USA) via drinking tap water for three weeks 
[9]. Memantine hydrochloride (Sigma, USA) was dissolved in PBS and 
intraperitoneally injected daily at dose of 10 mg/kg for three weeks.  
 
20. Statistical analysis. Statistical analyses were carried out using 
GraphPad Prism version 6.0. Differences between two groups were 
analyzed by using the two-tailed Student’s t and Fisher’s exact tests and 
considered to be statistically significant if the P value was < 0.05: *P < 





1. Ninj1 KO mice show hair loss and self-injuries 
To investigate the biological functions of Ninj1 in the CNS, we 
generated Ninj1 KO mice [16]. Some of them had dome-shaped heads 
and died within 2 months after birth (Figure 2A). In addition, 
approximately 2 % Ninj1 KO mice exhibit increased levels of motor 
hyperactivity compared with wild-type (WT) littermates, including 
repetitive circling (Figure 2B) and hyperlocomotion (Figure 2C), 
starting at 3 weeks of age. However, most of the homozygous Ninj1 
KO mice were healthy and similar to their wild-type (WT) littermates 










(A), Some Ninj1 KO mice had dome-shaped heads and small bodies 
Figure 2. Characterization of the abnormal phenotypes of the
Ninj1 KO mice. 
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and died within two months. (B, C), Some Ninj1 KO mice displayed 
circling behavior and hyperactivity in their cages. (B), A series of 
images showing that the Ninj1 KO mice ran repetitively in many circles. 
(C) Representative images of the trajectories (left) and a quantification 
of distance moved (cm) (right) of WT and the Ninj1 KO mice during a 
10-minute exploration of the cage (n = 6 mice per genotype). The error 












At the indicated times, no significant differences in body weight were 
observed between the genotypes for either males or females. Numbers 
of mice: P30, male, WT (n = 9); Hetero (n = 11); KO (n = 9); and 
female, WT (n = 7); Hetero (n = 9); KO (n = 8); P60, male, WT (n = 
10); Hetero (n = 11); KO (n = 9) and female, WT (n = 12); Hetero (n = 










Surprisingly, at three months of age, the Ninj1 KO mice began 
to develop hair loss (approximately 70 % penetrance; Figure 4A) and 
had hair trapped in their teeth (Figure 4B), suggesting that the Ninj1 
KO mice exhibited excessive grooming behaviors. Moreover, 
approximately 10 % of the Ninj1 KO mice developed lesions on their 
face, ear, eye, scruff, back, inguinal and axillary areas, in both male and 
female mice at 6–9 months of age, regardless of the presence of cage 
mates, thereby excluding the possibility that lesions were resulted by 
allo-grooming or fighting (Figure 5A). To check whether peripheral 
defects would be a reason for the lesions, I performed a sensory test but 
failed to see any difference between Ninj1 KO and WT mice (Figure 
5B). Thus, this phenotype is suggestive of excessive self-injurious 
behavior, which was reported in OCD-like mice with deficiencies in the 
Hoxb8, Sapap3, or Slitrk5 gene [8-10]. 
Hair loss was also observed in WT mice that were caged with 
the Ninj1 KO mice (Figure 6A). Specifically, when placing mice of 
each genotype together, the WT mice developed hair loss and then 
regrew the hair after they were separated from their Ninj1 KO 
counterparts (Figure 6B). These observations indicate that Ninj1 KO 
mice compulsively allo-groomed their cage mates, resulting in the hair 
34 
 
loss phenotype, which is very similar to the obsessive-compulsive 
spectrum disorder trichotillomania [33,34]. Collectively, these findings 
suggest that Ninj1 KO mice are reminiscent of mouse models of 






































Figure 4. Ninj1 KO mice show hair loss phenotype. 
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(A), Representative images of WT and Ninj1 KO mice at four months 
of age. Hair loss in Ninj1 KO mice, but not WT littermates. (B), 
Accumulation of hair in the teeth of the Ninj1 KO but not the WT mice. 
Representative images of trapped hair in the teeth of Ninj1 KO mice 
(middle, red arrowhead) and extracted from the teeth (right, red 









(A), Representative images showing injuries (yellow arrows) in various 
areas of Ninj1 KO mice. (B), Hot plate test was performed at 55 oC (n = 
10 to 13 mice per genotype). Ninj1 KO mice showed normal 













(A), Hair loss phenotype in both WT (blue arrowheads) and Ninj1 KO 
(red arrowheads) mice due to the allo-grooming behavior of the Ninj1 
KO mice. Mice were placed in the same cage (3 to 4 mice per 
genotype) at the time of weaning [approximately 25 days after birth 
(P25)]. (B), Ninj1 KO mice excessively allo-groomed their cage mates, 
Figure 6. Ninj1 KO mice allo-groom their cage mates. 
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which caused hair loss on their backs (indicated by a blue arrow). After 
they were separated from the Ninj1 KO mice, the WT mice re-grew 
their lost hair, illustrating the excessive allo-grooming behaviors of the 



















2. Ninj1 KO mice display increased repetitive and anxiety
-like behaviors but normal social interaction and cognitive
function  
Ninj1 KO mice and their WT littermates were subjected to a number of 
behavioral assays for neuropsychiatric disorders including tests for 
repetitive and anxiety-like behaviors as well as social interaction, motor, 
and cognitive tests.  
Repetitive behaviors are a heterogeneous group of behaviors 
present in many neuropsychiatric disorders and may manifest as motor 
stereotypies, such as washing hands, locking and unlocking doors, 
pulling hair, or self-injurious behaviors [3,35], which can be modeled in 
rodents via certain behavioral assays, including grooming and marble-
burying tests [9,27,28]. The abnormal phenotypes of Ninj1 KO mice 
suggested that they displayed excessive grooming behavior. 
Accordingly, subsequent measurements revealed increased duration of 
self-grooming in Ninj1 KO mice (Figure 7A). In addition to over-
grooming, the Ninj1 KO mice demonstrated compulsive-like behaviors 
in marble-burying (Figure 7B) and nestlet-shredding tests (Figure 7C) 
as they showed a marked increase in the number of marbles buried and 
percentage of shredded materials compared with WT littermates. 
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Anxiety is a typical feature of neuropsychiatric disorders such 
as ASD and OCD [36,37], and therefore, anxiety-like behaviors of 
Ninj1 KO mice and WT littermates were examined using two 
paradigms. In the open field test, Ninj1 KO mice spent less time in the 
center zone of the open field (Figure 8, A and B), whereas total 
activities were not different between the two genotypes (Figure 8C). 
Furthermore, Ninj1 KO mice explored the risk areas (open arms) less 
and the safe areas (closed arms) more than WT littermates (Figure 9) in 
the elevated plus maze test. Together, these results indicate that Ninj1 
KO mice were more anxious than their WT counterparts.  
Because Ninj1 KO mice display several symptoms of ASD, we 
next determined whether Ninj1 KO mice have deficits in social 
interaction, which are the most recognizable manifestation of autistic 
behaviors in humans [27,29]. In three-chamber test, which measured 
time a mouse spent in the compartment containing the social partner 
(Figure 10A) or in close interaction (Figure 10B), Ninj1 KO mice 
exhibited normal social interaction behavior as they displayed a 
preferential interaction with the social partner rather than with the 
empty cage, similar to WT littermates (Figure 10).  
Taking into account the contribution of motor deficits to 
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behavioral impairment, we further tested motor functions by footprint 
test. The motor activity of Ninj1 KO mice was indistinguishable from 
their WT littermates in both male and female mice (Figure 11).   
To examine whether the abnormal behavioral phenotypes in 
Ninj1 KO mice are associated with a gain or a loss of cognitive ability, 
we tested spatial learning and memory in Ninj1 KO mice using the 
Morris water maze (MWM) test (Figure 12). Ninj1 KO mice learned to 
locate and mount a visible platform as well as WT littermates (Figure 
12A). When the platform was hidden, both Ninj1 KO and WT mice 
showed similar learning curves in the training phase of the MWM test 
(Figure 12B). During the probe trial, Ninj1 KO and WT mice 
performed comparably as they both displayed a similar number of 
platform passes and a significant preference for the target versus the 
opposite quadrant (Figure 12, C-E). These results imply that Ninj1 KO 
mice show normal cognitive ability.  
Collectively, these data indicate that the repetitive and anxiety-
like behaviors of Ninj1 KO mice appear to be related with 





(A), Increased self-grooming in Ninj1 KO mice (n = 8 mice per 
Figure 7. Ninj1 KO mice show repetitive behaviors in marble-
burying (MBT) and nestlet-shredding tests (NST). 
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genotype). (B), Representative images of MBT from WT and Ninj1 KO 
mice (left) and a histogram (right) showing quantification of numbers 
of buried marbles over the course of 30 minutes (n = 9 mice per 
genotype). (C), Representative images of NST from WT and Ninj1 KO 
mice (left) and a quantification graph (right) presents the percentage 
(%) of material shredded after 30 minutes for each genotype [n = 16 
(WT) and 15 (KO)]. The Ninj1 KO mice groomed more time (A), 
buried more marbles (B), and shredded more material (C) compared 
with their WT littermates. All of the data are presented as the mean ± 
s.e.m.; *P < 0.05; ***P < 0.001; two-tailed Student’s t-test. The error 
bars indicate s.e.m.   























































WT and Ninj1 KO mice were evaluated using the open field test (OFT). 
(A, B) The graphs show the time in centre zone (A) and the frequency 
(number of centre zone visits; B) with which the Ninj1 KO mice and 
their WT littermates explored the centre zone of the open field arena; n 
= 16 mice per genotype. (C), Examples of the trajectories (left) and 
distance moved (m) (right) of WT and Ninj1 KO mice during a 10-
minute exploration of the open field. All of the data are presented as the 
mean ± s.e.m.; *P < 0.05; NS, not significant; two-tailed Student’s t-














Quantification graphs that show the time spent in the open arms (A), 
Figure 9. Ninj1 KO mice show anxiety-like behaviors in elevated
plus maze (EPM) test. 
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the number of entries into the open arms (B), the time spent in the 
closed arms (C), and the number of entries into the closed arms (D) in 
the EPM test; n = 14 (WT) and 11 (KO). Note that the Ninj1 KO mice 
spent less time in the open arms and more time in the closed arms than 
their WT littermates. All of the data are presented as the mean ± s.e.m.; 


















Three chamber tests. Ninj1 KO mice displayed normal social 
interactions as they spent more time exploring the compartment 
containing the social partner (A) and time in close interaction with the 
social partner (B), similar to WT mice did (n = 7 mice per genotype). 
*P < 0.05, **P < 0.01, ***P < 0.001; two-tailed Student’s t-test. Error 









In this test, mouse paws were dipped in ink (forepaw: red, hindpaw: 
blue) and mice were allowed to walk along a corridor (40 cm in length). 
Representative footprint images of WT and Ninj1 KO mice in FPT (A) 
and measurements of stride lengths (left) and base widths of forepaws 
(middle) and hind paws (right) were quantified (n = 9 mice per 
genotype) (B). Ninj1 KO mice had normal motor function compared 
with WT littermates in FPT. Scale bar: 2 cm. NS, not significant; two-
tailed Student’s t-test. Error bars indicate s.e.m. 
 
 
Figure 11. Ninj1 KO mice showed normal motor performance in




Figure 12. Ninj1 KO mice show normal spatial learning and
memory in Morris water maze test (MWM). 
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(A), Visible platform test. Ninj1 KO mice recognized the visible 
platform as well as WT littermates as indicated by escape latency (s). 
(B), Hidden platform test. The curves show latency to reach the hidden 
platform each day during spatial training in the MWM of WT (blue 
circles) and Ninj1 KO (red squares) mice. Ninj1 KO mice showed 
similar capacities to find the hidden platform when compared with WT 
littermates. (C-E), Probe trial test on day 6. Ninj1 KO mice swam 
similar distances (C) and had similar frequencies of crossing the former 
hidden platform site (D) relative to WT littermates. (E) Representative 
trajectory images (top) and graph (bottom) showing that WT and Ninj1 
KO mice exhibited comparable memory, as indicated by abilities to 
find the former hidden platform area (n = 9 to 12 mice per genotype). 
NS, not significant; two-tailed Student’s t-test. Error bars indicate s.e.m. 
Abbreviations: T, target; O, opposite; R, right; and L, left. Black 








3. Alleviation of behavioral abnormalities of Ninj1 KO  
mice by fluoxetine treatment  
I subsequently tested whether I could pharmacologically rescue the 
abnormal behaviors of Ninj1 KO mice by treating Ninj1 KO mice with 
fluoxetine, which is a FDA-approved SSRI drug for patients with 
depression or OCD and reportedly alleviates repetitive behaviors in 
mice [8,9,38]. Chronic oral administration of fluoxetine prevented the 
progression of hair loss (Figure 13) and reduced the duration of self-
grooming (Figure 14A) and anxiety-like behavior (Figure 14B) of 
Ninj1 KO mice without affecting their total activity (Figure 14C) in the 
open field test. Collectively, these results indicate that the aberrant 





















WT and Ninj1 KO mice were given vehicle (tap water) or fluoxetine (in 
drinking water) over the course of 3 weeks. Representative images 
(upper panel) and a quantification (lower panel) demonstrate that 
fluoxetine treatment prevented the progression of hair loss (arrows) in 
Ninj1 KO mice. ***P < 0.001; NS, not significant; Fisher's exact test. 
The number of mice used is included in the bar graph. 
 
Figure 13. Fluoxetine treatment prevented the progression of hair
loss in Ninj1 KO mice. 
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WT and Ninj1 KO mice were given vehicle (tap water) or fluoxetine (in 
drinking water) over the course of 3 weeks. Three weeks of fluoxetine 
treatment alleviated the excessive grooming (A) and anxiety-like 
behavior (B) of the Ninj1 KO mice without affecting the distance 
moved (m) (C) in the OFT [n = 9 (WT) and 7 (KO)]. All of the data are 
presented as the mean ± s.e.m.; *P < 0.05; NS, not significant; two-




Figure 14. Serotonin re-uptake inhibitor fluoxetine alleviates




4. Temporo-spatial expression of Ninj1 in the central  
nervous system (CNS) 
To gain an insight into the mechanisms that underlie the 
abnormal behaviors of the Ninj1 KO mice, I investigated the temporo-
spatial expression of Ninj1 in the CNS. I first observed that Ninj1 
gradually increased during the first two weeks of postnatal brain 
development (Figure 15); this expression pattern is similar to those of 
synaptic molecules such as neuroligin 1 (NL1), the NMDA receptor 
subunit 2A (NR2A), and synaptophysin, which suggests the 


























Figure 15. Temporal kinetics of Ninj1 expression during brain 
development. 
Representative Western blot (WB) of whole-brain lysates (upper panel) 
and the corresponding quantification of Ninj1 expression (lower panel; 
n = 3 mice per time point) during mouse brain development. 
Abbreviation: Synapto., synaptophysin. NL1, NR2A, and 
synaptophysin were included as markers of brain development. 
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Asterisks and hashtags above the data points indicate significance 
relative to day 0. *P < 0.05, **P < 0.01, #P < 0.0001; NS, not 




















 To identify the cell types that express Ninj1, I isolated brain 
tissue from mice that carried a “knockout-first” allele (tm1a) of Ninj1 
using lacZ as a reporter gene [26] (see Materials and Methods) and 
revealed that β-galactosidase, which indicates the expression of Ninj1, 
was mainly found in the thalamus, cortex, pituitary gland, and medulla 
oblongata (Figure 16). Moreover, double-labeling experiments 
explicitly demonstrated the predominantly neuronal expression of 








Figure 16. Spatial expression pattern of Ninj1 in mouse brain tissue. 
β-galactosidase (β-gal; arrowheads) staining of mouse brain tissue from 
Ninj1 mutant mice (Ninj1+/tm1a). Nuclear fast red (NFR) was used for 
counterstaining. (A), A sagittal section of mouse brain taken at low 
magnification that shows strong β-gal signals in Thal, Ctx, MO, and Pit. 
(B), A high magnification image of a sagittal section of mouse brain 
that also shows strong β-gal signals in the STN area. (C), β-gal is 
highly expressed in the Pir and dorsal Str in a coronal section of 
forebrain tissue. (D), In the mouse hippocampus, Ninj1 is most 
abundant in the CA2 region. Abbreviations: Thal, thalamus; Hip, 
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hippocampus; Ctx, cortex; OB, olfactory bulb; CB, cerebellum; MO, 
medulla oblongata; Pit, pituitary gland; STN, subthalamus nuclei; Str, 





















Figure 17. Ninj1 is prominantly expressed in CNS neurons. 
Immunostaining of a frontal cortex section with antibodies against β-
galactosidase (green, arrowheads) and NeuN (magenta) indicating the 
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localization of Ninj1 in neurons. (A), Low magnification. (B), High 
magnification. β-galactosidase expression had a spot-like pattern 
(arrowheads) and specificity was indicated by the absence of signals in 












Figure 18. Ninj1 is not expressed in either brain glial or endothelial 
cells. 
Double immunostaining of frontal cortex tissues from heterozygous 
Ninj1 mutant mice (Ninj1+/tm1a) with antibodies against β-galactosidase 
(anti-β-gal, magenta, arrowheads) and the brain cell-type specific 
markers GFAP (anti-GFAP, green, top) for astrocytes, MOG (anti-MOG, 
green, middle) for oligodendrocytes, and CD31 for endothelial cells 





In addition, I confirmed the expression of Ninj1 in cultured 
cortical neurons (Figure 19A), which showed a sharp increase in Ninj1 










Figure 19. Ninj1 is expressed in cortical neurons, and is 
upregulated during the neuronal differentiation process. 
(A), Representative differential interference contrast (DIC) images of 
primarily cultured cortical neurons from WT and Ninj1 knockout (KO) 
after 13 days in vitro (DIV 13; left) and Western blot analysis of Ninj1 
protein in cortical neuron lysates on DIV 13 (right). No Ninj1 signal 
was observed in Ninj1 KO cortical neuron lysates, indicating specificity 
of the Ninj1 antibody. ɑ-Tubulin was used as a loading control. Scale 
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bar, 50 µm. (B), Western blot analysis of Ninj1 protein levels in cortical 
neurons at indicated times. A representative Western blot data of 
primary cultures (left) from 3 independent experiments and 
quantification graph (right) are shown. Bands that corresponded to 
Ninj1 were quantified and normalized to α-Tubulin expression. Note 
that Ninj1 is upregulated during neuronal differentiation, along with the 
synaptic proteins NR2A (a post-synaptic molecule) and synaptophysin 
(a pre-synaptic molecule). α-Tubulin was used as a loading control. n = 
3 samples at each time point. Abbreviations: DIV, days in vitro; NR2A, 
N-methyl-D-aspartate (NMDA) receptor subunit 2A; Synapto., 
synaptophysin. Asterisks above the data points in (B, right) indicate 
significance relative to DIV 3. The error bars indicate the s.e.m.; *P < 










5. Synaptic localization of Ninj1 in neurons      
I next examined the localization of Ninj1 in neurons using biochemical 
fractionation of the mouse brain tissue. Ninj1 was highly enriched in 
synaptosomes, especially in the synaptic plasma membranes, as were 
with other synaptic proteins such as NR2A and PSD95 (Figure 20). 
Additionally, immunostaining of cultured cortical neurons transfected 
with either GFP-Ninj1 or Flag-Ninj1 revealed punctate expression of 
Ninj1 (Figure 21A), which overlapped with NL1 expression in 
dendritic spines (Figure 21B). Taken together, these results 














Figure 20. Subcellular localization of Ninj1. 
Immunoblotting was performed after subcellular fractionation of mouse 
brain tissue (n = 3 biologically independent repeats). Ninj1 was more 
abundant in synaptic fractions (P2, P2ʹ, and LP1) than in other 
subcellular fractions. Hom., homogenate; S1, synaptosome suspension; 
P1, nuclear pellet and debris; S2, light membrane and cytosolic 
fraction; P2, crude synaptosomal fraction; P2ʹ, washed synaptosomal 
fraction; S3, lysed synaptosomal fraction; LP1, synaptosomal 
membrane fraction; S3ʹ, crude synaptic vesicle fraction. NR2A and 





Figure 21. Ninj1 is localized at CNS synapses. 
(A), Primary cortical neurons were transfected with either GFP-Ninj1 
or Flag-Ninj1 on DIV 7. The neurons were fixed on DIV 11 and were 
immunostained with GFP (anti-GFP, green, left) or Flag (anti-Flag, 
magenta, right) antibodies. Ninj1 was expressed in puncta-like 
structures in both the GFP-Ninj1- and Flag-Ninj1-transfected neurons. 
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(B), Colocalization of Ninj1 with a synaptic adhesion molecule NL1. 
Cortical neurons that were co-transfected with expression constructs for 
Flag-Ninj1 and HA-NL1 were double labeled with anti-Flag (magenta) 
and anti-HA (green) antibodies. Scale bars, 50 µm (A); 20 µm (B, 


















6. Neuron-specific conditional Ninj1 KO mice recapitulate 
the aberrant phenotypes of Ninj1 KO mice 
To clarify whether deficiencies of neuron-derived Ninj1 lead to the 
abnormal behaviors observed in the Ninj1 KO mice, I generated Ninj1 
conditional KO mice (Ninj1 c.KO), which had Ninj1 specifically 
deleted in CNS neurons, by crossing Ninj1 floxed mice (see Materials 
and Methods and [26]) with synapsin-I-Cre mice, which express Cre 
recombinase specifically in CNS neurons [39] (Figure 22). As shown 
in Figure 23, Ninj1 protein level was dramatically reduced in Ninj1 
c.KO brains compared with that of control mice, indicating that Cre-
mediated recombination was successful and that neurons were the 
major source of Ninj1 in the mouse brains. Ninj1 c.KO mice showed 
accumulation of hair trapped in their teeth and the hair loss phenotype 
(Figure 24, A and B). Moreover, the Ninj1 c.KO mice spent less time 
exploring the open arms during the elevated plus maze test than their 
control littermates (Figure 24C), which indicates that the Ninj1 c.KO 
mice also displayed anxiety-like behavior. Therefore, the abnormal 
phenotypes of Ninj1 KO mice is likely attributable to the depletion of 























Figure 22. Generation and genotyping of the neuron-specific Ninj1 
conditional KO mice (Ninj1 c.KO).  
(A), Schematic diagram showing the strategy for the generation of the 
Ninj1 c.KO mice. In the WT allele, the yellow boxes with numbers 
represent exons, and the black dotted lines denote splice events. In the 
Ninj1tm1a mutant allele, a trapping cassette that included the LacZ and 
neo genes was inserted into the first intron of the Ninj1 gene and was 
flanked by FRT sites (green triangles). LoxP sites (red triangles) 
flanked the critical exon 2 of the Ninj1 gene, as indicated. The presence 
of an Engrailed (En2) Splice Acceptor (SA) disrupts Ninj1 gene 
function, which leads to lacZ fusion and localized gene expression. The 
relative positions of the PCR primers used for genotyping are presented. 
In the presence of Flp recombinase, the FRT sequences (green 
triangles) flank the trapping cassette are deleted, converting the 
potentially conditional Ninj1tm1a allele to a readily conditional Ninj1tm1c 
allele and restoring Ninj1 protein expression. Thus, mice that carry the 
Ninj1tm1c allele (Ninj1flox mice) can be considered as equivalent to WT 
mice. Subsequent breeding of the Ninj1flox mice with neuron-specific 
Cresyn mice led to the removal of the floxed exon 2 of the Ninj1tm1c 
allele, resulting in a Ninj1 conditional KO allele (Ninj1tm1d) in neurons. 
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The locations of the PCR primers used for genotyping are indicated by 
lavender arrows (Ftm1c and Rtm1c). (B), Genotyping of the Ninj1
tm1a mice. 
Representative agarose gels show the PCR product for each allele. The 
WT allele (+) produced one 612-base-pair (bp) band using primer pair 
1 (Ninj1-F and Ninj1-ttR), whereas the “knockout-first” allele 
(Ninj1tm1a) produced a single 274-bp band using primer pair 2 (LoxF 
and Ninj1-R). Heterozygous (hetero) mutant mice produced two bands 
of 612 and 274 bp. (C), Genotyping of the Ninj1 c.KO mice, see also 
Methods. Agarose gels show the PCR products. The Cresyn transgene 
produced one band of 300 bp, while the Ninj1tm1c allele produced one 





























Figure 23. Analysis of Ninj1 protein expression in Ninj1 c.KO and 
initial characterization of Ninj1 c.KO. 
(A), Brain homogenates were prepared from five-week-old control 
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(Ninj1+/-, Ninj1+/-; Cresyn, Ninj1-/flox) and Ninj1 c.KO (Ninj1-/flox; Cresyn) 
mice. Representative blots (top) and densitometric quantification 
(bottom) (n = 4 mice per genotype) that show Ninj1 protein levels in 
mouse brains of the indicated genotypes. β-Actin was used as a loading 
control. The Ninj1 protein levels were dramatically reduced in the 
Ninj1 c.KO brains compared with those of the control mice. (B), 
Immunoblot analysis of Ninj1 in spinal cords (top) and livers (bottom) 
of control and Ninj1 c.KO mice. Ninj1 protein levels were significantly 
reduced in the spinal cords but not in the livers of Ninj1 the c.KO mice 
relative to those in control mice, indicating by Cresyn-mediated Ninj1 
deletion specifically in CNS neurons. β-Actin was used as a loading 
control. (C), Ninj1 c.KO mice are indistinguishable from control 
littermates in gross morphology. Representative images of Ninj1 c.KO 
mice and control littermates at postnatal day 30 (upper panel) and a 
graph presenting body weights from both genders at postnatal day 65 
(lower panel). Numbers of mice: male, Ctrl (n = 10); Ninj1 c.KO (n = 
5); and female, Ctrl (n = 7); Ninj1 c.KO (n = 4). #P < 0.0001; NS, not 




Figure 24. Neuron-specific Ninj1 c.KO mice recapitulates key 
features of OCD-like behaviors. 
(A, B), Ninj1 c.KO mice allo-groomed their cage mates, leading to the 
trapping of hair in their teeth (arrowheads) and a hairless phenotype 
(arrows). (C), Ninj1 c.KO mice spent less time in the open arms than 
the controls in the EPM test [n = 13 (Ctrl) and 7 (c.KO)]. The error bars 
in (C) indicate the s.e.m. #P < 0.0001; NS, not significant; two-tailed 








7. Disruption of Ninj1 impairs neural circuits  
Although OCD reportedly reflects neural circuit dysfunction, the 
underlying mechanisms remain poorly characterized [8,9,38,40-43]. 
Thus, to pinpoint the mechanisms of the OCD-like behaviors of the 
Ninj1 KO mice, I performed anatomical, histological, and 
electrophysiological analyses of Ninj1 KO brains. Compared to WT 
littermates, the brain of the Ninj1 KO mice were less heavy (Figure 25), 
but did not exhibit differences in overall architecture (Figure 26). 
Therefore, neuronal morphology was examined in the Ninj1 KO mice 
using Golgi staining to visualize cortico-striatal circuits, which were 
highly activated in the Ninj1 KO mice (Figure 27) and have previously 
been implicated in the pathogenesis of OCD [8,9]. The dendritic 
complexity of the striatal medium spiny and cortical neurons of the 
Ninj1 KO mice was markedly decreased compared with that in the WT 
mice (Figure 28). These observations were supported by further assays 
that demonstrate that Ninj1 was important for dendritic branching in 















Figure 25. Ninj1 KO mice show reduced brain volume. 
Representative images (left) and quantification histogram of brain 
weights (n = 3 mice per genotype; right). Scale bar, 2 mm. ***P < 










Figure 26. Gross anatomical normalities in the brains of Ninj1 KO 
mice.  
(A), Nissl staining of coronal sections of the brains of WT and Ninj1 
KO mice. The dotted lines represent the borders between the cortex and 
striatum. Ninj1 KO mice have normal gross brain morphology 
compared with WT littermates. (B), Immunofluorescence confocal 
images of the cortex (layer I-IV) (upper) and striatum (lower) from WT 
and Ninj1 KO brains stained with a NeuN antibody (red; left) and 
quantification of neuronal density within each area (n = 3 mice per 
genotype; right). (C), Immunofluorescence images of hippocampal 
tissue of WT and Ninj1 KO mice that was stained with a NeuN 
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antibody (left) and the quantification of neuronal cell numbers in these 
areas (n = 3 mice per genotype; right). The neuronal density in the 
Ninj1 KO mice did not differ from that in their WT littermates. Scale 
bars, 50 µm (A); 200 µm (B); 500 µm (C, upper); 50 µm (C, lower). 












Figure 27. Hyperactivity of cortico-striatal circuit in Ninj1 KO 
mice.  
(A), A representative Western blot (left) and the corresponding 
quantification of c-Fos (a marker of neuronal activation) protein levels 
(n = 4 mice per genotype; right) are shown. (B), Confocal images show 
the upregulation of FosB (another marker of neuronal activation) in the 
84 
 
striatum of the Ninj1 KO mice compared with the expression in the WT 
littermates (n = 2 mice per genotype). Hoechst 33342 was used to 
counterstain nuclei. Scale bars, 200 µm (B). *P < 0.05; two-tailed 




















Figure 28. Ninj1 KO brain displays a decrease in dendritic 
complexity. 
Representative images of Golgi staining of striatal medium spiny 
neurons (MSNs) (left) and cortico-striatal areas (right) showing the 
reduced dendritic complexity of the neurons of the Ninj1 KO mice 
compared to that of the neurons of the WT littermates. Scale bars, 25 







Figure 29. Knockdown of Ninj1 results in decreased dendritic 
branching in cortical neurons.  
Primary cortical neurons were co-transfected with EGFP-N1 (for the 
visualization of neuronal morphology) and siCtrl or siNinj1 on DIV 4, 
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fixed with 4 % paraformaldehyde (PFA), and immunostained with GFP 
antibody on DIV 8. (A), Efficiency of Ninj1 knockdown in cortical 
neurons. A representative Western blot (left) and the corresponding 
quantification of Ninj1 protein levels (normalized to β-Actin; right) are 
shown. In the siNinj1-transfected neurons, Ninj1 protein levels were 
decreased to approximately 50 % of control levels. The presented data 
are representative of at least three independent primary cultures. (B), 
Knockdown of Ninj1 leads to reduced dendritic branching, as indicated 
by the number of primary dendrites that originated from the soma 
(white arrowheads) and the number of secondary dendrites that 
originated from the primary dendrites (yellow arrowheads) [n = 42 
(siCtrl) and 56 (siNinj1) neurons]. Scale bar, 200 µm. (C), 
Representative Sholl analysis of a neuron performed by counting the 
number of dendrite intersections (left). Graph shows quantification of 
Sholl analysis of primary cortical neurons transfected with the indicated 
siRNAs (right). #P < 0.0001; two-tailed Student’s t-test. The error bars 







Figure 30. Deficiency of Ninj1 reduces dendritic branching in 
cortical neuron. 
Ninj1 KO and WT primary cortical neurons were stained with MAP2 
antibody (red), a specific marker of dendrites at DIV 7. Ninj1 KO 





Moreover, Ninj1 ablation led to a substantial reduction in 
synapse number (Figure 31), which was in part due to reduced 
dendritic branching. In addition, Ninj1 promoted pre-synapse formation 
in vitro (Figure 32), suggesting that it is required not only for neuronal 













Figure 31. Ninj1 KO brain shows reduced number of synapses. 
Electron micrographs of brain sections of WT and Ninj1 KO mice in 
low magnification (A, upper) and in high one (B, lower) and 
quantification of synapse number [n = 20 (WT) and 17 (KO) images 
from 2 mice per genotype; C]. Arrowheads indicate synapses. Scale bar, 
500 nm (A); 100 nm (B). #P < 0.0001; two-tailed Student's t test. Error 





Figure 32. Ninj1 promotes pre-synapse formation in cortical 
neurons. 
(A), Artificial synapse formation assay. Primary cortical neurons on 
DIV 9 were co-cultured with HEK293T cells transfected with GFP-
mock or GFP-Ninj1, and fixed on DIV 11. Cells were then 
immunostained with synapsin (red) and GFP (green) antibodies. A cross 
section through a transfected HEK293T cell with synapsin punctas on 
top of cell surface expressing GFP-Ninj1. Ninj1 induced synapsin 
clustered on the cell surface, suggesting that it mediates pre-synapse 
formation. Yellow arrowheads: puncta on top of HEK293T cells, white 
arrowheads: regular interneuronal synapses surrounding HEK293T 
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cells. Data are representative of three independent cortical neuron 
cultures, 5-10 cells were analyzed at each culture. HA-NL1 was used as 
a positive control. Scale bar, 50 µm. (B), Knockdown of Ninj1 reduces 
the number of pre-synapses in cortical neurons. Cultured cortical 
neurons were transfected with siCtrl or siNinj1 on DIV 9, fixed with 
4 % PFA, and immunostained with a synapsin antibody (red) on DIV 
11. Representative confocal images (left) and the corresponding 
quantification (n = 11-12 images per group; right) are shown. (C), 
Ninj1 deficiency leads to decreased numbers of pre-synapses. Cultured 
cortical neurons from WT and Ninj1 KO mice were fixed with 4 % PFA, 
and were immunostained with a synapsin antibody (red) on DIV 11. 
Representative confocal images (left) and the corresponding 
quantification (n = 12 images per group; right) are shown. Scale bars, 
50 µm (A); 100 µm (B and C). **P < 0.01, #P < 0.0001; two-tailed 








8. Ninj1 deletion leads to reduced level of glutamate  
neurotransmitter in the mouse brain  
A body of evidence suggests that neurotransmitters, such as glutamate, 
dopamine, and serotonin are dysregulated in neuropsychiatric disorders, 
and this dysregulation may contribute to the pathophysiology of these 
disorders [44-46]. Thus, to address whether neurochemical changes are 
associated with the behavioral abnormalities of Ninj1 KO mice, I 
examined the levels of the main neurotransmitters in the mouse brain 
tissue using high performance liquid chromatography-electrochemical 
detection (HPLC-ECD). Interestingly, I found a reduction in the level 
of glutamate, which is the principal excitatory neurotransmitter in the 
brain (Figure 33A), but failed to observe any changes in the levels of 
norepinephrine, dopamine, and serotonin and its main metabolite, 5-
hydroxyindoleacetic acid (5-HIAA) in Ninj1 KO mice as compared to 
those of WT littermates (Figure 33B). Together, these results suggest 
the glutamate reduction in the brain could contribute to the abnormal 






Figure 33. Profile of major neurotransmitters in Ninj1 KO mice. 
Indicated neurotransmitter levels in cerebral cortex of Ninj1 KO mice 
and WT littermates were measured using high performance liquid 
chromatography-electrochemical detection (HPLC-ECD). Levels of 
glutamate (A) and norepinephrine, dopamine, serotonin, and the major 
metabolite of serotonin 5-hydroxyindoleacetic acid (5-HIAA) are 
shown [n = 4 (WT) and 3 (KO)] (B). Ninj1 KO mice showed reduced 
glutamate concentrations, but other neurotransmitter levels were normal 
compared with WT littermates. *P < 0.05; NS, not significant; two-







9. Ninj1 KO mice display altered synaptic transmission in
thalamic neurons  
Alteration of synaptic transmission has been reportedly associated with 
neuropsychiatric disorders [2,8,9,27]. Thus, to pinpoint the mechanisms 
of the aberrant behaviors of Ninj1 KO mice, in collaboration with Dr. 
Daesoo Kim (Department of Biological Sciences, Korea Advanced 
Institute of Science and Technology (KAIST), Korea), we performed an 
electrophysiological analysis in the ventral lateral thalamic nucleus, in 
accordance with the high expression of Ninj1 in the thalamus (Figure 
16). In whole-cell voltage-clamp recordings from acute brain slices, the 
frequency of miniature excitatory post-synaptic currents (mEPSCs) in 
slices from Ninj1 KO mice was significantly decreased (by 
approximately 50 %) compared to that in slices from WT littermates 
(Figure 34A), indicating a reduced number of functional synapses 
and/or reduced glutamate-mediated neurotransmission with 
postsynaptic receptors. Additionally, Ninj1 deletion led to increased 
amplitude of the mEPSCs (Figure 34B), suggesting a greater number 
of glutamate receptors per synapse in Ninj1 KO neurons compared with 
that in WT neurons. These data corroborate previous studies of 
abnormal neurotransmission in mouse cortico-striato-thalamo-cortical 
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circuits, which are well-known primary sites of synaptic dysfunction in 
neuropsychiatric disorders such as ASD and OCD [27,29,40,47]. Taken 
together, these results indicate that altered neural circuits are central to 



















Figure 34. Disruption of Ninj1 leads to altered glutamatergic 
synaptic transmission in thalamic neurons.  
Whole-cell patch-clamp electrophysiology of ventral lateral thalamic 
neurons shows the alterations of mEPSCs in Ninj1 KO mice. (A), 
Representative mEPSC recordings are shown. Scale bars, 20 pA and 
500 ms. (B, C), Cumulative plots and average values (insets) of 
mEPSC frequency (B) and amplitude (C); n (cells) = 7 (WT) and 8 
(KO) from 3 mice per genotype. *P < 0.05; two-tailed Student's t test. 





10. Ninj1 modulates glutamate signaling  
Synaptic transmission in neural circuits that control mouse 
behaviors could be modulated by ionotropic glutamate receptors. 
Accordingly, increasing evidence has implicated the dysregulation of 
glutamate signaling in the pathology of neuropsychiatric disorders such 
as OCD [47-50]. Here, I found that Ninj1 deficiency resulted in the 
upregulation of N-methyl-D-aspartate (NMDA) receptors (NR1, NR2A, 
and NR2B subunits) and α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptors (GluR1 and GluR2 
subunits) in synaptosomes of mouse brain tissue (Figure 35). These 
data suggest that Ninj1 could be involved in the regulation of synaptic 
transmission through ionotropic glutamate receptors. In addition, level 
of NR2A subunit was also increased in total brain lysates of Ninj1 KO 
mice compared with that of WT littermates (Figure 36A). Furthermore, 
knockdown of Ninj1 upregulated the NR1 and NR2A subunits of 
NMDARs in cultured neurons (Figure 36B), suggesting that Ninj1 is a 





Figure 35. Ninj1 modulates glutamate signaling at synapses.  
A representative WB (left) and the corresponding quantification (n = 3 
mice per genotype; right) show that Ninj1 deletion leads to the 
upregulation of NMDAR (including NR1, NR2A, and NR2B subunits) 
and AMPAR (including GluR1 and GluR2 subunits) protein levels in 
synaptosomes of mouse brain cerebrums. β-Actin was used as a loading 
control. **P < 0.01, ***P < 0.001; two-tailed Student's t test. Error bars 







Figure 36. Ninj1 regulates NMDAR protein levels in CNS neurons. 
(A), Ninj1 deletion leads to the upregulation of NMDAR protein levels 
in total lysates of mouse cerebrums. A representative Western blot (left) 
and the corresponding quantification (n = 4 mice per genotype; right) 
are shown. GAPDH was used as a loading control. (B), Knockdown of 
Ninj1 in neurons disrupted NMDAR protein levels. On DIV 4, cortical 
neurons were transfected with control (Ctrl) or Ninj1 siRNAs for three 
days. A representative Western blot (left) and the corresponding 
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quantification (n = 3 per condition; right) are shown. β-Actin was used 
as a loading control. **P < 0.01; NS, not significant;; two-tailed 




















Thus, to investigate the molecular mechanisms by which Ninj1 
regulates NMDARs, I initially co-transfected HEK293T cells with the 
NR2A subunit and Flag-mock or Flag-Ninj1 plasmids and monitored 
receptor expression. I observed a notable decrease in NR2A level in the 
presence of Ninj1 (Figure 37), which suggests that Ninj1 affects NR2A 
stability. In subsequent analyses of NR2A receptor turnover using 
cycloheximide pulse-chase experiments, Ninj1 facilitated NR2A 
















Figure 37. Ninj1 downregulates NR2A protein level in vitro.  
A representative WB (left) and the corresponding quantification (n = 3 
per time point; right) that show NR2A protein levels during co-
transfection of NR2A and Flag-mock or Flag-Ninj1 plasmids into 
HEK293T cells. β-Actin was used as a loading control. *P < 0.05, **P 











Figure 38. Ninj1 affects NR2A stability.  
Pulse-chase cycloheximide (CHX) assays in HEK293T cells that were 
co-transfected with NR2A and Flag-mock or Flag-Ninj1 plasmids. A 
representative WB (upper) and corresponding quantification (lower; n 
= 3 biologically independent repeats) that show NR2A protein levels 
during treatment. β-Actin was used as a loading control. *P < 0.05; NS, 
not significant; two-tailed Student's t test. Error bars indicate the s.e.m. 
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I next examined the membrane distribution of NR2A using cell 
surface biotinylation assays, and we noted that overexpression of Ninj1 
decreased the cell surface presentation of NR2A (Figure 39A). To 
confirm that Ninj1 regulates the cell membrane level of NR2A, I 
utilized a construct of NR2A in which a super-ecliptic pHluorin was 
used  to tag its extracellular N-terminus (SEP-NR2A); this tag 
produces green fluorescence upon localization at the pH-neutral cell 
membrane surface [51]. I consistently found that Ninj1 inhibited 
plasma membrane recruitment of SEP-NR2A in HEK293T cells 
(Figure 39B). Together, these results demonstrate the importance of 













Figure 39. Ninj1 inhibits membrane recruitment of NR2A.  
(A), HEK293T cells were co-transfected with NR2A and Flag-mock or 
Flag-Ninj1 plasmids for 24 hours. The cell surface proteins were then 
labelled with biotinylation reagent (NHS-Biotin) for 1 hour at 4oC. 
After the cells were lysed, the resulting proteins were pulled down with 
streptavidin-conjugated beads and then immunoblotted. A 
representative Western blot (left) and the corresponding quantification 
(n = 3 biologically independent repeats; right) that showed decreased 
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NR2A protein levels at the cell membrane surface. Na+-K+-ATPase was 
used as a plasma membrane marker. (B), HEK293T cells were co-
transfected with SEP-NR2A and Flag-mock or Flag-Ninj1 plasmids. 
Cells were then fixed and immunostained without detergents using an 
anti-Flag antibody (blue). Representative confocal images (left) and 
corresponding quantification (right; n = 15 images per group from at 
least 3 biologically independent repeats), which show that the green 
signal (SEP) was decreased in the presence of Ninj1. Scale bar, 100 µm. 














Finally, to translate these findings into therapeutic applications, 
I next evaluated the therapeutic potential of memantine, an NMDAR 
antagonist that has been approved for the treatment of Alzheimer's 
disease [52]. Intraperitoneal injections of this drug into injured Ninj1 
KO mice dramatically reduced clinical symptoms, including the extent 
of the injury (Figure 40A) and grooming times (Figure 40B). These 
observations closely agree with the results of several ongoing clinical 
trials of memantine for OCD and provide additional evidence for the 
“glutamate hypothesis” of OCD pathogenesis [53,54]. Collectively, the 
present findings suggest that abnormal glutamate signaling contributes 







Figure 40. Blocking of NMDA receptors alleviates abnormal 
behaviors of Ninj1 KO mice. 
Daily administration of 10 mg/kg memantine ameliorated the OCD-like 
behaviors of injured Ninj1 KO mice, including a reduction in the extent 
of injury (arrowheads; A) and in grooming time (n = 3 mice; B). #P < 
0.0001; two-tailed Student's t test. Error bars in all of the panels 










In the present study, I demonstrate for the first time that deletion 
of Ninj1 in mice leads to abnormal behaviors. Specifically, I showed 
that Ninj1 KO mice compulsively groomed their cage mates, leading to 
the hair loss phenotype. In addition, compared with WT mice, Ninj1 
KO mice were more anxious in the open field and elevated plus maze 
tests. These abnormal phenotypes could be rescued by chronic 
treatment with fluoxetine, a selective serotonin reuptake inhibitor 
(SSRI) reportedly used to ameliorate compulsive behaviors in mice and 
also a first-line drug for depression and OCD patients. I further 
demonstrated that Ninj1 was predominantly expressed in neurons of the 
cortico-thalamic circuits and mice with neuron-specific ablation of 
Ninj1 exhibited grooming-induced hair loss and anxiety-like behavior. 
Finally, I provided evidence of defects in brains of Ninj1 KO mice in 
histological, electrophysiological, and biochemical analyses. 
Modeling psychiatric disorders such as OCD, ASD, and 
schizophrenia is highly challenging. Although there have been 
numerous studies on psychiatric disorders in humans, their underlying 
mechanisms have not been clarified because it is typically unacceptable 
to intervene with human genes. Additionally, psychiatric disorders are 
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heterogeneous with the potential involvement of a battery of genes; 
hence, genetic mouse models are needed. Mouse models are paving the 
way toward insights into neuropsychiatric disorders at multiple levels, 
from molecular, physiological to behavioral levels [55]. With the 
availability of genetic manipulation, mouse models facilitate 
identification of new candidate genes related to these diseases. Using a 
set of behavioral assays, I found that Ninj1 KO mice manifested 
behavioral abnormalities, including repetitive and anxiety-like 
behaviors. Ninj1 KO mice compulsively groomed, leading to hair 
removal and lesions similar to the reported mice with ASD- or OCD-
like behaviors, such as Shank3-, Sapap3-, or Slitrk5-deficient mice 
[8,9,27]. Importantly, Ninj1 KO mice also groomed their cage mates, 
suggesting that excessive grooming behavior is unlikely attributable to 
peripheral nervous system or skin abnormalities. Furthermore, 
individuals with a specific psychiatric disorder commonly experiences 
additional psychiatric disorder simultaneously or at some time during 
their lifetime [56-59]. Thus, it might be argued that the abnormal 
behaviors existing in Ninj1 KO mice might be a shared feature of 
several psychiatric disorders, such as OCD and autistic-like behaviors. 
Nevertheless, my results indicate that Ninj1 KO mice exhibited normal 
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social interactions and cognitive function, thereby excluding the ASD-
like behaviors.   
OCD is characterized by obsessions and compulsions; most 
patients experience both symptoms throughout the course of their 
illness, while some only show one or the other . Obsessions are 
repetitive, intrusive, unwanted thoughts that are often about cleanliness, 
religion, safety, or violence and are associated with anxiety. 
Compulsions are repetitive behaviors, typically associated with specific 
obsessions to neutralize the anxiety [36]. Affected individuals are 
unable to control either the thoughts or the behaviors, leading to 
substantial morbidity [2,3]. OCD is incompletely understood; however, 
neuroimaging studies have implicated the cortico-striato-thalamo-
cortical (CSTC) circuits in the pathophysiology of OCD [2,41,60]. In 
addition, genetic and treatment studies have further demonstrated the 
involvement of glutamatergic dysfunction within the CSTC circuits as 
the underpinning etiology of OCD and the OC-spectrum disorders 
[47,48,61]. Here, my data indicate that Ninj1 is predominantly 
expressed in cortico-thalamic circuits and involved in regulating 
synaptic transmission in the brain. In addition, in the same line with the 
“glutamate hypothesis” of OCD pathogenesis [46,62], I found that 
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Ninj1 deletion led to glutamatergic alterations in the CNS. Notably, 
Ninj1 KO mice were responsive to fluoxetine, which is an effective 
treatment for OCD patients and reportedly alleviates OCD-like 
behaviors in mice. Collectively, the biochemical, electrophysiological, 
and pharmacological studies further support a possibility of presence of 
OCD-like behaviors in Ninj1 KO mice. 
A critical feature of my findings is that Ninj1 is predominantly 
expressed in CNS neurons; hence, the behavioral abnormalities of 
Ninj1 KO mice might be caused by altered neural circuits. Consistently, 
conditional KO mice lacking Ninj1 specifically in CNS neurons 
recapitulated the abnormal phenotypes of global Ninj1 KO mice, 
confirming that the loss of neuron-derived Ninj1 is primarily 
responsible for these defects. In addition, Ninj1 appears to be localized 
at synapses, which are the sites mediating signal transmission between 
neurons. Changes in synaptic function have been described in a wide 
range of neuropsychiatric disorders, such as ASD, OCD, depression, 
and schizophrenia [47,63-67]. Thus, I speculate that altered synaptic 
transmission in the brain of Ninj1 KO mice could be a plausible link to 
the etiology of the behavioral aberrations. Supporting this hypothesis, I 
observed a reduction in the frequency and an increase in the amplitude 
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of mEPSCs in the thalamic neurons of Ninj1 KO mice. These results 
are notable because synaptic dysfunctions within the cortico-striato-
thalamo-cortical (CSTC) circuits are widely accepted in ASD and OCD 
[2,27,47]. Therefore, an important question that needs to be addressed 
is how Ninj1 deficiency causes synaptic dysfunctions. I noticed that 
Ninj1 deletion led to glutamatergic abnormalities in the CNS. The 
brains of Ninj1 KO mice showed increased levels of glutamate 
receptors in synaptosomal fractions, in strong agreement with an 
increase in the mEPSC amplitudes of neurons. On the other hand, the 
level of glutamate neurotransmitter was found to be downregulated in 
the brains of Ninj1 KO mice, which coupled with a reduction in 
synapse number substantiated the decrease in the mEPSC frequency of 
neurons. Further investigation would be required to determine the exact 
mechanisms by which Ninj1 modulates the glutamatergic abnormalities. 
Identifying partners of Ninj1 in the brain could pave the way to fulfill 
this task. 
Interestingly, I found postsynaptic adhesion molecule localized 
at glutamatergic synapses neuroligin 1 (NL1), a postsynaptic adhesion 
molecule localized at glutamatergic synapses, but not NL2, as a 
potential binding partner by series of immunoprecipitation (IP) assays 
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(Figure 41) and immunocytochemical analysis in HEK293T cells, 
Neuro2A (a mouse neural crest-derived cell line), and cultured neurons 
co-overexpressing Ninj1 and NL1 (Figure 42, A-C). Specifically, in 
dendrites of mature neurons, Ninj1 was co-localized precisely with 
NL1 at spines (Figure 42D). These data suggest that Ninj1 could 
interact with NL1, thereby moderating CNS synapses including the 
synapse formation and activity. It is noteworthy to notice that mice 
deficient for Nlgn1, which encodes for NL1, exhibited increased 
repetitive behaviors, including grooming behavior [68]. Thus, the 
coupling of NL1 and Ninj1 might be the key for normal brain function 
and disruption of this interaction could lead to abnormal behaviors as 
seen in Nlgn1 or Ninj1 KO mice. 
My findings reveal that chronic administration of fluoxetine 
alleviated the behavioral deficits of Ninj1 KO mice. There are several 
possibilities for explaining the mechanisms underlying the alleviating 
effects of fluoxetine. First, fluoxetine inhibits 5-hydroxytryptamine 
(HT) receptors in pre-synaptic neurons to increase the availability of 5-
HT (known as serotonin) at post-synaptic receptors [69]. However, the 
levels of serotonin neurotransmitter and its main metabolite 5-HIAA in 
Ninj1 KO mice were comparable with those of WT littermates. Since 
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the functions of 5-HT receptors in the brains of Ninj1 KO mice have 
not yet been examined, there is a possible involvement of 
neurotransmission mediated by these receptors in affecting the 
abnormal behaviors of Ninj1 KO mice. Second, the therapeutic efficacy 
of fluoxetine could be associated with other processes in addition to its 
effects on serotonin receptors. In several recent studies, it has been 
reported that fluoxetine exhibits direct inhibitory effects on the NMDA 
receptors [70-72]. Similarly, I found that disruption of Ninj1 led to the 
increased synaptic expression of the ionotropic glutamate receptors and 
amplitude of the mEPSCs. Therefore, I speculate that fluoxetine might 
block the glutamate receptors to mitigate the compulsive grooming and 
anxiety-like behaviors in Ninj1 KO mice. Taken together, 
serotoninergic and glutamatergic neurotransmission, either 
independently of each other or coordinately, could mediate the 
behaviors of Ninj1 KO mice. The latter postulation in particular merits 
further investigation. 
To find any mutations of NINJ1 in human OCD patients, I have 
thoroughly examined the published articles (via PubMed, 
https://www.ncbi.nlm.nih.gov/pubmed/) as well as public data sources 




(GeneCards®: The Human Gene Database, http://www.genecards.org/), 
and OMIM (Online Mendelian Inheritance in Man, 
https://www.ncbi.nlm.nih.gov/omim) and have not found any genetic 
mutations in NINJ1 in human OCD or anxiety patients. However, in a 
genome-wide association study (GWAS) of OCD conducted by the 
International OCD Foundation Genetic Collaborative (IOCDF-GC) 
[73], we found that some single nucleotide polymorphisms (SNP) of 
other genes such as rs9641218, rs1876359, and rs11869351 statistically 
significantly affect NINJ1 mRNA level and status of NINJ1 methylation 
in brain tissue of human OCD patients by eQTL (expression 
quantitative trait loci) and mQTL (methylation quantitative trait loci) 
analyses. Thus, the roles of Ninj1 in human neuropsychiatric disorders 
such as OCD or anxiety disorders would benefit from further 
investigation.  
Several questions need to be addressed in the future. First, in 
addition to the contribution of Ninj1 in glutamatergic synaptic 
transmission that I have found in this study, it would be interesting to 
further explore other roles of Ninj1 in the thalamic circuit. Using 
combinatorial tools of optogenetic techniques [74] and Ninj1 
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conditional KO mice, which lack Ninj1 specifically in this brain area 
through the utilization of Cre mice bearing thalamic-specific promoters 
such as potassium voltage-gated channel subfamily C member 2 (Kcnc2, 
or Kv3.2) and somatostatin (som) [75,76], would be helpful in 
elucidating the functions of Ninj1 in thalamus and OCD. Next, 
although this study provided profound evidence of the defects of neural 
circuits in Ninj1 KO mice, a potential involvement of oxidative stress, 
which has been reportedly to play roles in animal behaviors and 
neuropsychiatric diseases including OCD [77-79], shoud be determined. 
It would be valuable to test effects of antioxidants such as N-acetyl 
cysteine (NAC) on the abnormal behaviors of Ninj1-deficient mice. In 
clinical studies, NAC has been demonstrated to improve the clinical 
symptoms of OCD patients [80,81]. Furthermore, the therapeutic effect 
of NMDA receptor antagonists such as memantine on the hair loss 
phenotype of Ninj1 KO mice remains uncharacterized and would merit 
further investigation. 
In conclusion, my findings provide evidence that Ninj1 is a 
molecular link between impaired neural circuits, altered glutamate 
signaling, and OCD-like behaviors in mice (Figure 43). Therefore, I 
propose that Ninj1 is a strong candidate for mutation scanning in OCD 
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patients and that Ninj1-deficient mice are an appropriate model for 
future studies of OCD, which opens opportunities for the development 



















Figure 41. Ninj1 interacts with Neuroligin 1, but not Neuroligin 2 in 
vitro. 
(A), Immunoprecipitation assays (IP) were performed in HEK293T 
cells co-overexpressing with GFP mock or GFP-mouse Ninj1 and 
various HA-tagged isoforms of Neuroligin 1 [NL1 (-); NL1A; NL1B; 
NL1AB] and Neuroligin 2 [NL2 (-); NL2A] as indicated. Total protein 
lysates were immunoprecipitated with mouse anti-HA antibody and 
subsequently immunoblotted with GFP and HA antibodies. Normal 
mouse IgG was used as a non-specific control. Hashtag (#) indicates 
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GFP, while arrow (↓) shows GFP-Ninj1. Arrowhead (►) denotes the 
site of immunoprecipitated protein (GFP-Ninj1). Note that Ninj1 binds 
to all NL1 isoforms, but not NL2 isoforms. (B), Inversed IP strategy 
was conducted. IP assays were performed in HEK293T cells co-
transfected with HA-NL1 (-) and GFP mock or GFP-Ninj1 by using 
GFP antibody. The subsequent Western blots were probed using the 
indicated antibodies. Note that HA-NL1 (-) was co-immunoprecipitated 
with GFP-Ninj1, but not with GFP mock. (C, D) The interaction 
between Ninj1 and NL1 was further confirmed in 3XFlag tagged form 
of Ninj1 by using IP with Flag antibody (C) and inverse IP with HA 
antibody (D). In both cases, NL1 were found to be co-
immunoprecipitated with Ninj1 (C) and vice versa (D). (E), To exclude 
to possibility that tags (GFP- and 3XFlag-) could influence the binding 
of Ninj1 and NL1, we generated a non-tagged form of Ninj1 
[pcDNA3.1-Myc/His-mouse Ninj1] with a stop codon inserted after 
Ninj1 coding sequence and before Myc/His sequences] and applied IP 
assays with HA antibody. These assays clearly confirmed the 
interaction between Ninj1 and NL1. Molecular weight (kDa) is shown 
on the right of each blot. Asterisks (*) represent the 
immunoprecipitated proteins. ɑ-Tubulin and β-actin were probed as 
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loading controls. Similar results were replicated in at least two 










































Figure 42. Ninj1 interacts with Neuroligin 1 in vivo. 
(A, B) Confocal images showing the colocalization of Ninj1 (green) 
and NL1 immunostained in red in co-transfected HEK293T cells (A) 
and mouse Neuro 2A cells (B). (C), Colocalization of Ninj1 and NL1 
isoforms in neurons. Cortical neurons (DIV 4) were co-transfected with 
GFP-Ninj1 and indicated NL1 isoforms including NL1 (-), NL1A, and 
NL1AB. Samples were fixed and double immunostained on DIV 10 
with HA (red) and GFP (green) antibodies. Confocal images showed 
complete colocalization of Ninj1 and indicated NL1 isoforms in 
neurons. (D), Ninj1 is expressed in dendritic spines with similar pattern 
to NL1. Primary cortical neurons were co-transfected with Flag-Ninj1 
and HA-NL1 on DIV 4 and fixed on DIV 11. Samples were then double 
immunostained with Flag (red) and HA (green) antibodies. Scale bars: 






























Figure 43. Proposed model for the mechanisms that underlie the 
OCD-like behaviors of the Ninj1-deficient mice. 
Ninj1 is highly expressed in cortico-thalamic circuits (red colour in a 
cartoon of a sagittal section of the mouse brain), especially in neurons, 
and is required for the maintenance of neural circuits. Thus, the 
disruption of Ninj1 results in reduced neuronal branching, decreased 
numbers of functional synapses, and abnormalities in glutamate 
signaling. The resulting altered neurotransmission then leads to the 














In addition to the contribution of Ninj1 to neuronal branching 
and synapse formation, my preliminary data demonstrated that Ninj1 
could involve in neurogenesis, a process by which neurons are 
generated from the neural stem cells and progenitor cells (Figure 44, A 
and B). In the mouse brain, Ninj1 is highly expressed in neuroblast 
cells (PSA-NCAM (+)) of subventricular zone (SVZ) of lateral 
ventricle (LV) (data not shown) and rostral migratory stream (RMS) 
(Figure 44C). It would be of great interest to test the functions of Ninj1 
in neurogenesis as this process is important for maintaining neuronal 
population in brain and for repairing circuits after injuries such as 





Figure 44. The possible involvement of Ninj1 during neurogenesis. 
(A) P19 embryonic stem cell was induced to differentiation by retinoic 
acid (RA). The levels of Ninj1 during the was examined by Western 
blott. (B) Retinoic acid (RA)-induced P19 cells at day 5 (upper) and 
day 6 (lower) were double stained with antibodies against Ninj1 (green) 
and Nestin or Tuj1 (red), respectively. (C) Ninj1 (green) is expressed in 
neuroblasts of RMS and LV as seen by their coexpression of the marker 
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ABSTRACT IN KOREAN (국문초록) 
Ninjurin1 결손 마우스에서 강박 장애 
유사증상 발현에 관한 연구 
 
강박증(Obsessive-compulsive disorder, OCD)은 강박관념 
(obsession)과 불안에 근거한 반복적인 행동 (compulsion)을 
주된 특징으로 하는 정신질환으로 세계 인구의 약 2 % 가량이 
이 질환을 앓고 있다고 알려져있다. 분자 신경생물학의 
발전으로 생쥐에서 인간의 강박증과 유사한 증세를 일으키는 
유전자들이 일부 발견되었지만, 정신신경계 질환의 복잡성으로 
인하여 몇 가지 유전자가 아닌, 다양한 유전자 및 인자들이 
관여하는 것으로 보이며, 발병 원인 및 진행 과정을 이해하기 
위하여 관련 유전자 발굴 및 그 분자 기전에 대한 집중적인 
연구가 필요한 상황이다. 
본 논문은 신경재생과 염증반응에 관련되어 있다고 
알려져 있는 세포 부착 단백질인 Ninjurin1 (Ninj1) 과 강박증의 
144 
 
연관성을 연구하였다. Ninj1 결손 생쥐는 대표적인 강박증 
증상인 반복 행동 및 불안 행동과 함께, compulsive grooming에 
의한 hair loss를 보였으며, 이들에게서 자해로 인한 상처 (self-
made lesion)를 관찰할 수 있었다. Ninj1은 조직학적으로 뇌의 
cortico-thalamic circuits에 주로 발현되었으며, global Ninj1 K/O뿐 
아니라, 신경조직에 Ninj1을 선택적으로 K/O시킨 생쥐에서도 
유사한 이상 행동을 보였다. 특히, Ninj1 K/O 생쥐의 뇌를 
관찰한 결과, 시냅스의 수와 뉴런의 branching이 현저히 감소해 
있었으며, thalamic neuron의 신경 시냅스 전달 (synaptic 
transmission)에 이상을 나타내었다. 또한 Ninj1 K/O 생쥐는 
글루타메이트 레벨 감소 및 이온성 글루타메이트 수용체 
증가와 같은 glutamatergic 증세가 발현되었다. 이러한 이상 
행동이 면역/염증 반응 이상에 의한 결과가 아니라 
신경정신장애 행동임을 검증하기 위하여, Ninj1 K/O 생쥐에 
강박장애 행동을 완화시키는 약물인 fluoxetine을 투여한 결과, 
compulsive grooming과 불안 장애 행동이 완화되고, hair loss의 
진행이 멈춤을 확인하였다. 즉, Ninj1 K/O 생쥐에서 관찰한 
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이상 행동이 강박 장애와 유사함을 규명하였다. 
따라서, 본 연구는 Ninj1 이 생쥐 뇌신경의 정상적인 
분화 및 기능에 관여하며, Ninj1 K/O 생쥐에서 반복 및 불안 
증상을 나타냄을 규명하여, 강박증의 발병 및 진행에 Ninj1이 
관련될 가능성을 제시하였다. 이러한 결과는 신경정신장애 
질환의 기전 이해 및 치료제 개발에 기여할 수 있을 것이라 
기대된다. 
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